Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Trius Therapeutics Inc (TSRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/13/2013 |
4
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| EASTHAM KARIN (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 6,000 shares
@ $0
Disposed/sold 12,114 shares
@ $0
Disposed/sold 17,441 options to buy
@ $7.57, valued at
$132k
Disposed/sold 6,000 options to buy
@ $3.5, valued at
$21k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| O'Leary Brendan (Director) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| Schmid John P. (CFO) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| TRUEX PAUL F (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 11,270 shares
@ $0
Disposed/sold 12,403 options to buy
@ $1.29, valued at
$16k
Disposed/sold 12,000 options to buy
@ $3.5, valued at
$42k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| MORNEAU MICHAEL (VP Finance & CAO) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| Stein Jeffrey (President & CEO) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 210,457 shares
@ $0
Disposed/sold 81,280 options to buy
@ $0.52, valued at
$42.3k
Disposed/sold 156,976 options to buy
@ $1.29, valued at
$202.5k
Disposed/sold 30,813 options to buy
@ $1.29, valued at
$39.7k
Disposed/sold 200,000 options to buy
@ $3.5, valued at
$700k
Disposed/sold 250,000 options to buy
@ $4.8, valued at
$1.2M
Disposed/sold 275,000 options to buy
@ $6.13, valued at
$1.7M
|
|
| 09/13/2013 |
4
| KABAKOFF DAVID S (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 5,285 shares
@ $0
Disposed/sold 106,081 shares
@ $0
Disposed/sold 18,000 options to buy
@ $3.5, valued at
$63k
Disposed/sold 18,000 options to buy
@ $8.26, valued at
$148.7k
Disposed/sold 18,000 options to buy
@ $5.05, valued at
$90.9k
Disposed/sold 21,000 options to buy
@ $7.77, valued at
$163.2k
|
|
| 09/13/2013 |
4
| Onaitis Matthew (General Counsel) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 100,000 options to buy
@ $7.67, valued at
$767k
|
|
| 09/13/2013 |
4
| Fischer Seth H.Z. (Director) has filed a Form 4 on Trius Therapeutics Inc |
| 09/13/2013 |
4
| ATWOOD BRIAN G (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 9,302 options to buy
@ $1.29, valued at
$12k
Disposed/sold 12,000 options to buy
@ $3.5, valued at
$42k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| Kjellson Nina S (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 9,302 options to buy
@ $1.29, valued at
$12k
Disposed/sold 12,000 options to buy
@ $3.5, valued at
$42k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| Schroeder Theodore R (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 15,116 options to buy
@ $7.57, valued at
$114.4k
Disposed/sold 12,000 options to buy
@ $3.5, valued at
$42k
Disposed/sold 12,000 options to buy
@ $8.26, valued at
$99.1k
Disposed/sold 12,000 options to buy
@ $5.05, valued at
$60.6k
Disposed/sold 15,000 options to buy
@ $7.77, valued at
$116.6k
|
|
| 09/13/2013 |
4
| THOMPSON JOHN CRAIG (Chief Commercial Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 07/23/2013 |
4
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 07/16/2013 |
4
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 3,500 shares
@ $10.55, valued at
$36.9k
|
|
| 07/12/2013 |
4
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 1,000 shares
@ $8.58, valued at
$8.6k
Sold 500 shares
@ $9.32, valued at
$4.7k
Sold 5,000 shares
@ $10.1, valued at
$50.5k
|
|
| 07/12/2013 |
4
| MORNEAU MICHAEL (VP Finance & CAO) has filed a Form 4 on Trius Therapeutics Inc |
| 07/01/2013 |
4
| Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 07/01/2013 |
4
| Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 06/12/2013 |
4
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 3,000 shares
@ $9.0833, valued at
$27.2k
|
|
| 06/11/2013 |
4
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 1,000 shares
@ $8.94, valued at
$8.9k
|
|
| 06/11/2013 |
4/A
| Finn John (Chief Scientific Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 3,000 shares
@ $7.475, valued at
$22.4k
|
|
| 06/04/2013 |
4
| Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 2,000 shares
@ $7.9, valued at
$15.8k
|
|
| 06/03/2013 |
4
| Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc |
| 06/03/2013 |
4
| Onaitis Matthew (General Counsel) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Granted 100,000 options to buy
@ $7.67, valued at
$767k
|
|
| 06/03/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/28/2013 |
4
| Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 12,000 shares
@ $7.9266, valued at
$95.1k
|
|
| 05/28/2013 |
4/A
| Bartizal Ken (Chief Development Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 12,000 shares
@ $7.85, valued at
$94.2k
|
|
| 05/28/2013 |
4
| Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 12,000 shares
@ $7.9266, valued at
$95.1k
|
|
| 05/28/2013 |
4/A
| Prokocimer Philippe (Chief Medical Officer) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 12,000 shares
@ $7.65, valued at
$91.8k
|
|
| 05/23/2013 |
4
| Fischer Seth H.Z. (Director) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Granted 2,500 options to buy
@ $7.77, valued at
$19.4k
|
|
|
|
|